Display options
Share it on

J Am Coll Clin Pharm. 2021 Jun 08; doi: 10.1002/jac5.1470. Epub 2021 Jun 08.

Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic.

Journal of the American College of Clinical Pharmacy : JACCP

Katie Kish, Sanela Lekic

Affiliations

  1. Department of Pharmacy Cleveland Clinic - Main Campus Cleveland Ohio USA.
  2. Department of Pharmacy Cleveland Clinic - Beachwood Beachwood Ohio USA.

PMID: 34226885 PMCID: PMC8242517 DOI: 10.1002/jac5.1470

Abstract

Due to community transmission of coronavirus disease 2019 (COVID-19), social distancing and stay-at-home orders were implemented statewide in an effort to limit the spread of disease. This posed unique challenges for patients on medications requiring close and continued monitoring by clinic staff, such as anticoagulation clinics. Thus, innovative measures were implemented at Cleveland Clinic Health System (CCHS) to maintain the health and care of ambulatory patients. An initiative to evaluate patients for warfarin to direct oral anticoagulants (DOAC) conversion was used in the pharmacist-run anticoagulation clinics. This article describes how patients were screened for eligibility, the education to pharmacists, the utilization of student learners in the process, and the workflow for provider notification of conversion. Follow up monitoring, challenges encountered, and future directions are also described.

© 2021 Pharmacotherapy Publications, Inc..

Keywords: COVID‐19; DOAC; ambulatory care; anticoagulation; pharmacy services; warfarin

Conflict of interest statement

The authors declare no conflicts of interest.

References

  1. J Pharm Pract. 2020 Jun;33(3):271-275 - PubMed
  2. Heart Rhythm. 2019 Aug;16(8):e66-e93 - PubMed
  3. J Thromb Thrombolysis. 2020 Jul;50(1):72-81 - PubMed
  4. Blood Adv. 2020 Oct 13;4(19):4693-4738 - PubMed
  5. Am J Health Syst Pharm. 2017 Apr 1;74(7):483-489 - PubMed
  6. Chest. 2016 Feb;149(2):315-352 - PubMed
  7. Pharmacotherapy. 2017 Oct;37(10):1284-1297 - PubMed
  8. Am J Cardiovasc Drugs. 2020 Aug;20(4):301-309 - PubMed

Publication Types